
Tuesday, July 14, 2020 3:09:22 PM

Liked By
Spread the love. Be the first to like this post!
Recent INMB News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/15/2023 08:04:01 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/03/2023 09:48:34 PM
- INmune Bio, Inc. Announces 2022 Results and Provides Business Update • GlobeNewswire Inc. • 03/02/2023 09:05:52 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/22/2023 09:01:19 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/22/2023 09:01:14 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/21/2023 09:10:30 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/21/2023 09:08:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/21/2023 09:07:10 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/21/2023 09:05:33 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/21/2023 09:04:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/21/2023 09:03:19 PM
- INmune Bio, Inc. to Report Fourth Quarter and Full-Year 2022 Results and Provide a Corporate Update on Thursday, March 2 • GlobeNewswire Inc. • 02/21/2023 02:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/10/2023 11:11:19 AM
- INmune Bio, Inc. Receives Approximately $6.4 Million in Research and Development Rebates from Australia and the United Kingdom • GlobeNewswire Inc. • 02/08/2023 01:45:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/25/2023 02:08:03 PM
- INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 01/25/2023 12:45:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/22/2022 09:01:20 PM
- INmune Bio, Inc., Virginia Commonwealth University, and Barrow Neurological Institute Receive Department of Defense Funding to Study the Role of Traumatic Brain Injury in the Development of Alzheimer’s Disease • GlobeNewswire Inc. • 12/22/2022 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 10:04:48 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/09/2022 09:01:51 PM
- Maxim Group Keeps Their Buy Rating on Inmune Bio (INMB) • TipRanks • 12/09/2022 06:55:06 PM
- INmune Bio, Inc. Data at ASH Highlight Innovative Natural Killer Cell Therapeutic Platform Showing 100+ Day Persistence of Cancer Killing Memory Like NK Cells in Patients with AML/MDS Following Treatment with INKmune™ • GlobeNewswire Inc. • 12/08/2022 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/07/2022 09:02:30 PM
- INmune Bio, Inc. Reports Combination Therapy with INB03™ Overcomes Resistance to Trastuzumab-Deruxtecan in MUC4 expressing HER2+ Breast Cancer • GlobeNewswire Inc. • 12/06/2022 09:00:00 PM
- INmune Bio, Inc. Focused on Novel Clinical Trial Designs to Advance Next Generation of Alzheimer’s Disease Treatments • GlobeNewswire Inc. • 11/29/2022 01:00:00 PM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
FEATURED Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • Mar 28, 2023 8:26 AM
FEATURED Edison Lithium Provides Update on Spin-Out of Cobalt Assets • Mar 28, 2023 8:09 AM
FEATURED Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM